Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Amazon One Medical has launched a GLP-1 management program that integrates primary care, pharmacy services and virtual care options to simplify the patient experience. The program aims to address ...

Amazon is launching a weight management program with access to GLP-1s through its One Medical primary care chain, in a bid to help consumers more easily access the popular weight loss drugs alongside ...

Amazon has launched a new weight management program through Amazon One Medical that integrates primary care, pharmacy services and virtual care to support patients using GLP-1 medications. The program ...

Opposition parties are likely to write a letter to Prime Minister Narendra Modi, urging him to implement the women’s reservation law of 2023 immediately by delinking it from the delimitation process.

WASHINGTON — The U.S. Space Force selected 14 companies to compete for contracts under a new $1.8 billion procurement of satellites and supporting technologies to monitor activity in geosynchronous ...

Feeling the monetary hit from tax season? To help with additional burdens from property taxes, New Jersey offers a trio of programs to provide some relief. These programs include Affordable New Jersey ...

The maker of the GLP-1 weight-loss drug Wegovy is promising “a lower, predictable monthly price” for patients who use a new subscription program for the medication. The savings add up to $600 a year ...

Texas has excluded about two dozen Islamic schools from its new $1 billion voucher program for allegedly being linked to terrorist groups, a decision that has led to a lawsuit and claims of ...

A home blood pressure telemonitoring program effectively reduced blood pressure in real-world clinical settings, but program enrollment expenses increased overall costs. Objectives: To evaluate the 12 ...

GLP-1 weight-loss drugs have quickly become some of the most sought-after medications in the United States, but their price tags have also made them one of the most difficult benefits for employers ...